TABLE 3.

Projected Outcomes of Conjugate Meningococcal Vaccination of US Birth and Adolescent Cohorts: Median and 5th and 95th Percentiles

No VaccinationVaccinationOutcomes Prevented
Adolescent strategy
    Cases598 (497–683)328 (182–417)270
    Deaths77 (57–92)41 (23–58)36
    Life-years lost/saved3766 (2703–4812)1968 (1021–2815)1798
    QALYs lost/saved3577 (1572–6084)1772 (698–3453)1805
Toddler strategy
    Cases1088 (972–1206)703 (606–817)385
    Deaths81 (66–96)48 (38–59)33
    Life-years lost/saved4419 (3635–5237)2799 (2249–3439)1620
    QALYs lost/saved9003 (4016–14 894)6210 (2760–10 317)2793
Infant strategy
    Cases1088 (972–1206)641 (570–710)447
    Deaths81 (66–96)45 (37–53)36
    Life-years lost/saved4419 (3635–5237)2583 (2124–3058)1836
    QALYs lost/saved9003 (4016–14 894)5574 (2459–9224)3429